4.4 Article

Dietary nitrate supplementation improves exercise performance and decreases blood pressure in COPD patients

期刊

NITRIC OXIDE-BIOLOGY AND CHEMISTRY
卷 48, 期 -, 页码 22-30

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.niox.2014.10.007

关键词

Chronic obstructive pulmonary disease; Nitrate; Nitrite; Nitric oxide; Exercise; Blood pressure

资金

  1. Translational Science Center on the Reynolda Campus at Wake Forest University
  2. National Institutes of Health [NR011186]

向作者/读者索取更多资源

Dietary nitrate (NO3-) supplementation via beetroot juice has been shown to increase the exercise capacity of younger and older adults. The purpose of this study was to investigate the effects of acute NO3- ingestion on the submaximal constant work rate exercise capacity of COPD patients. Fifteen patients were assigned in a randomized, single-blind, crossover design to receive one of two treatments (beetroot juice then placebo or placebo then beetroot juice). Submaximal constant work rate exercise time at 75% of the patient's maximal work capacity was the primary outcome. Secondary outcomes included plasma NO3- and nitrite (NO2-) levels, blood pressure, heart rate, oxygen consumption (VO2), dynamic hyperinflation, dyspnea and leg discomfort. Relative to placebo, beetroot ingestion increased plasma NO3- by 938% and NO2- by 379%. Median (+interquartile range) exercise time was significantly longer (p = 0.031) following the ingestion of beetroot versus placebo (375.0 + 257.0 vs. 346.2 + 148.0 s, respectively). Compared with placebo, beetroot ingestion significantly reduced iso-time (p = 0.001) and end exercise (p = 0.008) diastolic blood pressures by 6.4 and 5.6 mmHg, respectively. Resting systolic blood pressure was significantly reduced (p = 0.019) by 82 mmHg for the beetroot versus the placebo trial. No other variables were significantly different between the beetroot and placebo trials. These results indicate that acute dietary NO3- supplementation can elevate plasma NO3- and NO2- concentrations, improve exercise performance, and reduce blood pressure in COPD patients. (C) 2014 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据